Journal Home
Search for

Volume 48, Issue 3, Pages 535-545.e3 (September 2008)


View previous. 10 of 77 View next.

The Powerlink system for endovascular abdominal aortic aneurysm repair: Six-year results

Presented at the Annual Meeting of the Society for Vascular Surgery, Baltimore, Md, June, 2007.

Endologix InvestigatorsGrace J. Wang, MD, Jeffrey P. Carpenter, MDCorresponding Author Informationemail address

Received 21 January 2008; accepted 10 April 2008. published online 18 July 2008.

Objective

We compared the results of endovascular repair using the Powerlink endovascular graft with conventional open abdominal aortic aneurysm repair through a 6-year follow-up period.

Methods

Two hundred fifty-eight patients with abdominal aortic aneurysms were prospectively enrolled in a multicenter trial and underwent endovascular repair (N = 192) or conventional open surgery (N = 66). All endovascular repairs were approached through a surgically exposed femoral artery and a percutaneously accessed femoral artery. Study endpoints included all-cause mortality and morbidity. Follow-up imaging consisted of contrast-enhanced CT scans and plain abdominal x-rays at 1, 6, 12 months, and annually postoperatively.

Results

Technical success was achieved in 97.9% of test patients, with four failed insertions (three early conversions because of deployment issues, one access failure). Mean follow-up was 4.1 ± 1.7 years (test group) and 3.1 ± 1.9 years (control group). Perioperative morbidity and mortality were significantly reduced in the test group compared with the control group (P < .05). At 6 years, all-cause mortality and morbidity was no different in the Powerlink group compared with the open repair group. There were no reported stent fractures, graft disruptions, or aneurysm ruptures. Core laboratory-reported endoleaks included proximal or distal type I (n = 1) and type I/II (n = 3), with no type III or type IV endoleaks. One explant (0.5%) was undertaken to resolve a refractory type I endoleak. A total of 37 secondary procedures were performed in 26 patients to treat site-reported endoleak (n = 26; 7 for type I and 19 for type II), graft limb occlusion (n = 7), native artery occlusion (n = 3), or endograft migration (n = 1). A reduction in mean aneurysm sac diameters and volumes has been noted at every follow-up interval.

Conclusion

Consistent with other reports, perioperative morbidity and mortality were significantly reduced in the endovascular group compared with the open repair group. Six-year follow-up of patients treated with the Powerlink system demonstrates the continued safety and efficacy of its treatment of abdominal aortic aneurysm.

University of Pennsylvania School of Medicine, Philadelphia, Pa

Corresponding Author InformationReprint requests: Jeffrey P. Carpenter, MD, 4 Silverstein HUP, 3400 Spruce St, Philadelphia, PA 19104

 Additional material for this article may be found online at www.jvascsurg.org.

 Competition of interest: Dr Carpenter owns shares in Endologix, Inc.

PII: S0741-5214(08)00641-1

doi:10.1016/j.jvs.2008.04.031


View previous. 10 of 77 View next.